Medtronic received FDA approval for the Affera mapping and ablation system and Sphere-9 catheter, which can deliver both PFA ...

Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced United States Food and Drug ...

Medtronic (MDT) announced FDA approval of the Affera Mapping and Ablation System with Sphere-9 Catheter, an all-in-one, high-density mapping ...

Medtronic said the Food and Drug Administration approved its Affera mapping and ablation system with sphere-9 catheter.

The FDA approved an early feasibility study of Medtronic’s Affera mapping and ablation system and Sphere-9 catheter in ...

The study aims to assess the Catheter and Affera system in patients who have ventricular tachycardia (VT) due to scarring ...

Medtronic (NYSE: MDT) announced today that the FDA approved an early feasibility study to evaluate its Affera system for ...

Madi, left, and Affera write letters to addiction at Camp Mariposa in Sarasota, Florida. Katie Kindelan/ABC News In some cases, like Madi's, campers have lost a parent to substance abuse ...

Affera, a 14-year-old camper in Sarasota, said she grew up watching her dad abuse alcohol. Through camp, she said she has learned that her dad's substance abuse issues are, "not because he doesn't ...